Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
Clinical trial NCT00784303 · COMPLETED
Trial details
- NCT number
- NCT00784303
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-06
- Primary completion
- 2011-04-11
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.